{
    "title": "Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults",
    "abstract": "Background The early detection of oral cavity squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMD), followed by appropriate treatment, may improve survival and reduce the risk for malignant transformation respectively. This is an update of a Cochrane Review first published in 2013.    Objectives To estimate the diagnostic test accuracy of conventional oral examination, vital rinsing, light\u2010based detection, mouth self\u2010examination, remote screening, and biomarkers, used singly or in combination, for the early detection of OPMD or OSCC in apparently healthy adults.    Search methods Cochrane Oral Health's Information Specialist searched the following databases: Cochrane Oral Health's Trials Register (to 20 October 2020), MEDLINE Ovid (1946 to 20 October 2020), and Embase Ovid (1980 to 20 October 2020). The US National Institutes of Health Trials Registry (ClinicalTrials.gov) and the World Health Organization International Clinical Trials Registry Platform were searched for ongoing trials. No restrictions were placed on the language or date of publication when searching the electronic databases. We conducted citation searches, and screened reference lists of included studies for additional references.    Selection criteria We selected studies that reported the test accuracy of any of the aforementioned tests in detecting OPMD or OSCC during a screening procedure. Diagnosis of OPMD or OSCC was provided by specialist clinicians or pathologists, or alternatively through follow\u2010up.    Data collection and analysis Two review authors independently screened titles and abstracts for relevance. Eligibility, data extraction, and quality assessment were carried out by at least two authors independently and in duplicate. Studies were assessed for methodological quality using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS\u20102). We reported the sensitivity and specificity of the included studies. We provided judgement of the certainty of the evidence using a GRADE assessment.    Main results We included 18 studies, recruiting 72,202 participants, published between 1986 and 2019. These studies evaluated the diagnostic test accuracy of conventional oral examination (10 studies, none new to this update), mouth self\u2010examination (four studies, two new to this update), and remote screening (three studies, all new to this update). One randomised controlled trial of test accuracy directly evaluated conventional oral examination plus vital rinsing versus conventional oral examination alone. There were no eligible studies evaluating light\u2010based detection or blood or salivary sample analysis (which tests for the presence of biomarkers for OPMD and OSCC). Only one study of conventional oral examination was judged as at overall low risk of bias and overall low concern regarding applicability.  Given the clinical heterogeneity of the included studies in terms of the participants recruited, setting, prevalence of the target condition, the application of the index test and reference standard, and the flow and timing of the process, the data could not be pooled within the broader categories of index test. For conventional oral examination (10 studies, 25,568 participants), prevalence in the test accuracy sample ranged from 1% to 51%. For the seven studies with prevalence of 10% or lower, a prevalence more comparable to the general population, the sensitivity estimates were variable, and ranged from 0.50 (95% confidence interval (CI) 0.07 to 0.93) to 0.99 (95% CI 0.97 to 1.00); the specificity estimates were more consistent and ranged from 0.94 (95% CI 0.88 to 0.97) to 0.99 (95% CI 0.98 to 1.00). We judged the overall certainty of the evidence to be low, and downgraded for inconsistency and indirectness.  Evidence for mouth self\u2010examination and remote screening was more limited. We judged the overall certainty of the evidence for these index tests to be very low, and downgraded for imprecision, inconsistency, and indirectness. We judged the evidence for vital rinsing (toluidine blue) as an adjunct to conventional oral examination compared to conventional oral examination to be moderate, and downgraded for indirectness as the trial was undertaken in a high\u2010risk population.    Authors' conclusions There is a lack of high\u2010certainty evidence to support the use of screening programmes for oral cavity cancer and OPMD in the general population. Frontline screeners such as general dentists, dental hygienists, other allied professionals, and community healthcare workers should remain vigilant for signs of OPMD and OSCC.",
    "review_type": "Diagnostic",
    "doi": "https://doi.org/10.1002/14651858.CD010173.pub3",
    "review_id": "CD010173",
    "criteria": {
        "Types of studies": "Eligible study designs were cross\u2010sectional studies (or prospective consecutive series) and randomised controlled trials (RCTs) of test accuracy. Where randomised or paired comparative designs were available these were included in the review and analysed separately. We excluded case series and diagnostic case\u2010control studies which have been shown to lead to inflated estimates of prevalence and test accuracy (Whiting 2004). We also excluded studies that reported in abstract form alone, uncontrolled reports, and randomised controlled trials of the effectiveness of screening programmes (intervention studies). Only studies reporting test accuracy data in the form of a 2 x 2 table or where a 2 x 2 table could be constructed from the information in the study report were included.",
        "Participants": "Apparently healthy adults not reporting symptoms of oral potentially malignant disorders (OPMD) or oral squamous cell carcinoma (OSCC), attending an organised screening or surveillance programme, or screened during attendance at a dental or physician examination. We did not exclude specific subgroups of patients in this review, such as high\u2010risk cohorts or surveillance cohorts.",
        "Index tests": "Eligible index tests included: conventional oral examination (COE)/visual inspection by a dentist, physician, or other healthcare worker;    vital staining or rinsing (e.g. toluidine blue, tolonium chloride);   oral cytology (e.g. OralCDx brush biopsy, Cyte ID);   light\u2010based detection (e.g. VELscope, Orascoptic DK, Identafi 3000, ViziLite Plus, Microlux/DL);    mouth self\u2010examination;   remote clinical examination (including telemedicine); and   blood and saliva analyses. conventional oral examination (COE)/visual inspection by a dentist, physician, or other healthcare worker; vital staining or rinsing (e.g. toluidine blue, tolonium chloride); oral cytology (e.g. OralCDx brush biopsy, Cyte ID); light\u2010based detection (e.g. VELscope, Orascoptic DK, Identafi 3000, ViziLite Plus, Microlux/DL); mouth self\u2010examination; remote clinical examination (including telemedicine); and blood and saliva analyses.",
        "Target conditions": "Following the consensus views of the expert working group of the World Health Organization (WHO) Collaborating Centre for Oral Cancer/Precancer (Warnakulasuriya 2007; Warnakulasuriya 2021a), the following OPMDs and malignancies were considered as constituting a diseased classification: OSCC; OPMD represent a heterogeneous group of conditions including leukoplakia, erythroplakia, proliferative verrucous leukoplakia, oral lichen planus/oral lichenoid lesions, oral submucous fibrosis, and actinic keratosis (Warnakulasuriya 2007; Warnakulasuriya 2020). Where studies evaluated COE by someone other than a dentist or physician, or mouth self\u2010examination, the target condition of the index test was typically expressed as the presence or absence of an oral lesion.",
        "Reference standards": "The reference standard was examination and clinical evaluation by a clinician with specialist knowledge or training, working to the current diagnostic guidelines of their locality. At the most experienced level, this would be an oral and maxillofacial pathologist or oral medicine specialist, possibly utilising biopsy with histology where clinically appropriate. More commonly, this was expected to include general dentists in receipt of supplementary training in the detection and identification of OPMDs and OSCCs. We included studies where confirmation of individuals who were screened as negative by the index test was obtained from extended follow\u2010up. To be eligible for inclusion in the review, at least a proportion of the screened negatives were required to be verified. For each study we noted the diagnostic protocol, guidelines or registry used for follow\u2010up in the Characteristics of included studies table. Studies with confirmatory biopsy of individuals who were screened as negative by the index test were eligible for inclusion although ethically questionable (Downer 2004). Where a histopathological reference standard was employed this review classified any level of dysplasia (mild, moderate, or severe) as disease\u2010positive."
    },
    "search_strategy": {
        "Appendix 1. Cochrane Oral Health's Trials Register search strategy": "Cochrane Oral Health\u2019s Trials Register is available via the Cochrane Register of Studies. For information on how the register is compiled, see oralhealth.cochrane.org/trials.  From April 2019, searches of Cochrane Oral Health's Trials Register were conducted using the Cochrane Register of Studies software and the search strategy below:  1 ((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*):ti,ab) AND (INREGISTER)2 ((tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010 cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*):ti,ab) AND (INREGISTER)3 ((screen* or cytodiagnosis or cytophotometry or \"brush biops*\" or \"oral cdx\" or oralcdx or \"modified liquid based cytology\" or \"exfoliat* cytolog*\" or \"tolonium chloride\" or \"toludine b*\" or \"toluidine b*\" or tblue or t\u2010blue or \"toludine dye*\" or \"toludine rins*\" or \"toludine stain*\" or \"toludine wash*\" or \"toluidine dye*\" or \"toluidine rins*\" or \"toluidine stain*\" or \"toluidine wash*\" or luminescence or fluorescen* or \"light emitting diode*\"):ti,ab) AND (INREGISTER)4 (((blood or saliva) AND (analys* or inspect* or test or examin*)):ti,ab) AND (INREGISTER)5 ((\"blue spectrum\" or LED or luminous or \"visual* adjunct*\" or vizilite or microlux* or orascoptic or velscope or lumenoscope* or autofluorescen* or chemilumiescen* or spectrophotometr* or \"acetic acid\" or acetowhite or \"tumor marker*\" or \"tumour marker*\" or \"neoplas* marker*\"):ti,ab) AND (INREGISTER)6 ((diagnos* AND (exam* or histolog* or check* or screen*)):ti,ab) AND (INREGISTER)7 (#1 and #2) AND (INREGISTER)8 (#3 or #4 or #5 or #6) AND (INREGISTER)9 (#7 and #8) AND (INREGISTER)  Previous searches were conducted using the Procite software and the search strategies below:  ((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*) AND (cytodiagnosis or cytophotometry or \"brush biops*\" or \"oral cdx\" or oralcdx or \"modified liquid based cytology\" or \"exfoliat* cytolog*\" or \"tolonium chloride\" or \"toludine b*\" or \"toluidine b*\" or tblue or t\u2010blue or \"toludine dye*\" or \"toludine rins*\" or \"toludine stain*\" or \"toludine wash*\" or \"toluidine dye*\" or \"toluidine rins*\" or \"toluidine stain*\" or \"toluidine wash*\" or luminescence or fluorescen* or \"light emitting diode*\"))  ((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*) AND (\"blue spectrum\" or LED or luminous or \"visual* adjunct*\" or vizilite or microlux* or orascoptic or velscope or lumenoscope* or autofluorescen* or chemilumiescen* or spectrophotometr* or \"acetic acid\" or acetowhite or \"tumor marker*\" or \"tumour marker*\" or \"neoplas* marker*\"))  ((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*) AND (diagno* and (blood or saliva) and (analys* or inspect* or test* or examin*)))  ((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*) AND (diagnos* AND (exam* or histolog* or check or inspect* or screen*)))",
        "Appendix 2. MEDLINE Ovid search strategy": "1. exp Mouth/ 2. Cheek/ 3. or/1\u20102 4. exp Carcinoma, squamous cell/di 5. exp Precancerous conditions/di 6. (tumor$ or tumour$ or cancer$ or carcinoma$ or carcinogen$ or neoplas$ or malignan$ or metasta$ or dysplas$ or lesion$ or ulcer$).tw,ot. 7. (pre\u2010cancer$ or precancer$ or premalignan$ or precursor$ or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or (actinic adj2 keratosis) or candidiasis or erythroplakia or erythroplas$ or erythroleukoplakia or hyperplas$ or hyperkeratos$).tw,ot. 8. or/4\u20107 9. 3 and 8 10. exp Mouth neoplasms/di 11. Lichen Planus, Oral/di 12. Oral submucous fibrosis/di 13. Oral candidiasis/di 14. ((oral$ or mouth$ or bucca$ or \"oral cavit$\" or (oral adj mucosa$) or (mouth adj mucosa$) or lip or lips or tongue$ or gingiv$ or palat$ or cheek$ or \"intra oral$\" or intraoral$ or gum or gums or labial$) adj3 (tumor$ or tumour$ or cancer$ or carcinoma$ or carcinogen$ or neoplas$ or malignan$ or metasta$ or dysplas$ or lesion$ or ulcer$ or pre\u2010cancer$ or precancer$ or premalignan$ or precursor$ or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or (actinic adj2 keratosis) or candidiasis or erythroplakia or erythroplas$ or erythroleukoplakia or hyperplas$ or hyperkerato$)).tw,ot. 15. or/10\u201014 16. 9 or 15 17. Cytodiagnosis/ 18. Cytological techniques/ 19. Cytophotometry/ 20. (brush adj3 biops$).tw,ot. 21. (\"oral cdx\" or oralcdx).tw,ot. 22. (\"modified liquid based cytology\" or (exfoliat$ adj3 cytolog$)).tw,ot. 23. (brush$ and (cytodiagnosis or cytopathology)).tw,ot. 24. Tolonium chloride/ 25. Coloring agents/du 26. (\"tolonium chloride\" or \"tolu?dine blue\" or \"tolu?dine b\" or tblue or t\u2010blue).tw,ot. 27. (tolu?dine adj6 (dye$ or rins$ or stain$ or wash$)).tw,ot. 28. exp Luminescence/ 29. Fluorescence/ 30. Spectrometry, fluorescence/ 31. exp Luminescent Agents/ 32. Light/ 33. Tomography, Optical Coherence/ 34. (visual$ adj5 (\"light emitting diode\" or \"blue spectrum\" or LED or luminous$)).tw,ot. 35. (visuali?ation adj3 adjunct$).tw,ot. 36. (vizilite or microlux$ or orascoptic or velscope).tw,ot. 37. lumenoscop$.tw,ot. 38. ((tumor$ or tumour$ or cancer$ or carcinoma$ or neoplas$ or carcinogen$ or malignan$ or metata$ or lesion$ or ulcer$) adj5 (fluorescen$ or autofluorescen$ or luminescen$ or chemiluminescen$)).tw,ot. 39. (tissue adj3 reflect$).tw,ot. 40. Spectrophotometry/ 41. Acetic acid/ 42. (acetic acid adj3 (wash$ or rins$)).tw,ot. 43. acetowhite.tw,ot. 44. Saliva/an, ch 45. Tumor Markers, Biological/an 46. ((\"tumo?r marker$\" or \"neoplas$ marker$\") adj3 (blood or saliva)).tw,ot. 47. ((analy$ or screen$ or test$ or examin$) adj3 (blood or saliva)).tw,ot. 48. Diagnosis, Oral/ 49. Mass screening/ 51. screen$.mp. 50. Physical examination/ 51. ((oral$ or mouth$) adj5 (exam$ or histolog$ or check$ or inspect$)).tw,ot. 52. (visual$ adj3 (exam$ or inspect$ or screen$)).tw,ot. 53. or/17\u201052 54. 16 and 53",
        "Appendix 3. Embase Ovid search strategy": "1. exp Mouth/ 2. Cheek/ 3. or/1\u20102 4. exp Squamous cell carcinoma/di 5. exp Precancer/di 6. (tumor$ or tumour$ or cancer$ or carcinoma$ or carcinogen$ or neoplas$ or malignan$ or metasta$ or dysplas$ or lesion$ or ulcer$).tw,ot. 7. (pre\u2010cancer$ or precancer$ or premalignan$ or precursor$ or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or (actinic adj2 keratosis) or candidiasis or erythroplakia or erythroplas$ or erythroleukoplakia or hyperplas$ or hyperkeratos$).tw,ot. 8. or/4\u20107 9. 3 and 8 10. exp Mouth tumor/di 11. Lichen planus/di 12. Thrush/di 13. ((oral$ or mouth$ or bucca$ or \"oral cavit$\" or (oral adj mucosa$) or (mouth adj mucosa$) or lip or lips or tongue$ or gingiv$ or palat$ or cheek$ or \"intra oral$\" or intraoral$ or gum or gums or labial$) adj3 (tumor$ or tumour$ or cancer$ or carcinoma$ or carcinogen$ or neoplas$ or malignan$ or metasta$ or dysplas$ or lesion$ or ulcer$ or pre\u2010cancer$ or precancer$ or premalignan$ or precursor$ or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or (actinic adj2 keratosis) or candidiasis or erythroplakia or erythroplas$ or erythroleukoplakia or hyperplas$ or hyperkerato$)).tw,ot. 14. or/10\u201013 15. 9 or 14 16. Cancer cytodiagnosis/ 17. Cytophotometry/ 18. (brush adj3 biops$).tw,ot. 19. (\"oral cdx\" or oralcdx).tw,ot. 20. (\"modified liquid based cytology\" or (exfoliat$ adj3 cytolog$)).tw,ot. 21. (brush$ and (cytodiagnosis or cytopathology)).tw,ot. 22. Tolonium chloride/ 23. Coloring agent/ 24. (\"tolonium chloride\" or \"tolu?dine blue\" or \"tolu?dine b\" or tblue or t\u2010blue).tw,ot. 25. (tolu?dine adj6 (dye$ or rins$ or stain$ or wash$)).tw,ot. 26. exp Luminescence/ 27. Fluorescence/ 28. Spectrofluorometry/ 29. exp Luminescent Agents/ 30. Light/ 31. Tomography, Optical Coherence/ 32. (visual$ adj5 (\"light emitting diode\" or \"blue spectrum\" or LED or luminous$)).tw,ot. 33. (visuali?ation adj3 adjunct$).tw,ot. 34. (vizilite or microlux$ or orascoptic or velscope).tw,ot. 35. lumenoscop$.tw,ot. 36. ((tumor$ or tumour$ or cancer$ or carcinoma$ or neoplas$ or carcinogen$ or malignan$ or metata$ or lesion$ or ulcer$) adj5 (fluorescen$ or autofluorescen$ or luminescen$ or chemiluminescen$)).tw,ot. 37. (tissue adj3 reflect$).tw,ot. 38. Spectrophotometry/ 39. Acetic acid/ 40. (acetic acid adj3 (wash$ or rins$)).tw,ot. 41. acetowhite.tw,ot. 42. Tumor Marker/ 43. ((\"tumo?r marker$\" or \"neoplas$ marker$\") adj3 (blood or saliva)).tw,ot. 44 ((analy$ or screen$ or test$ or examin$) adj3 (blood or saliva)).tw,ot. 45. Mass screening/ 46. screen$.mp. 47. Physical examination/ 48. ((oral$ or mouth$) adj5 (diagnos$ or exam$ or histolog$ or check$ or inspect$)).tw,ot. 49. (visual$ adj3 (exam$ or inspect$ or screen$)).tw,ot. 50. or/16\u201049 51. 15 and 50",
        "Appendix 4. US National Institutes of Health Ongoing Trials Register (ClinicalTrials.gov) search strategy": "Condition: oral cancer Other terms: diagnosis or diagnose Condition: oral cancer Other terms: screen or screening",
        "Appendix 5. World Health Organization International Clinical Trials Registry Platform search strategy": "oral cancer AND diagnosis OR oral cancer AND diagnose OR oral cancer AND diagnostic oral cancer AND screen OR oral cancer AND screening",
        "Appendix 6. Search strategies used in the previous version of this review (April 2013)": "Cochrane Diagnostic Test Accuracy Register search strategy ((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*)    MEDION search strategy Searched using the code C (malignancies), and screened the results for oral cancer terms.",
        "Cochrane Diagnostic Test Accuracy Register search strategy": "((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*)",
        "MEDION search strategy": "Searched using the code C (malignancies), and screened the results for oral cancer terms."
    }
}